SHENZHEN GUDELI TECHNOLOGY CO., LTD. – Trademark Portfolio

Entity Type: 11

SHENZHEN GUDELI TECHNOLOGY CO., LTD. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include MYINGER. The owner is based in ROOM 301-B057, BUILDING 2, NO. 1, MAWU R.

ROOM 301-B057, BUILDING 2, NO. 1, MAWU

ROAD,, BAOAN COMMUNITY, YUANSHAN STREET,LONGGANG, DISTRICT

ROOM 301-B057, BUILDING 2, NO. 1, MAWU R , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

MYINGER
MYINGER
Registered 2019

Trademark Classifications

SHENZHEN GUDELI TECHNOLOGY CO., LTD.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does SHENZHEN GUDELI TECHNOLOGY CO., LTD. have?

SHENZHEN GUDELI TECHNOLOGY CO., LTD. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does SHENZHEN GUDELI TECHNOLOGY CO., LTD. file in?

SHENZHEN GUDELI TECHNOLOGY CO., LTD. files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are SHENZHEN GUDELI TECHNOLOGY CO., LTD.'s most well-known trademarks?

SHENZHEN GUDELI TECHNOLOGY CO., LTD.'s registered trademark portfolio includes well-known marks such as MYINGER. These are among 1 currently registered trademark in the portfolio.

What is SHENZHEN GUDELI TECHNOLOGY CO., LTD.'s trademark registration success rate?

SHENZHEN GUDELI TECHNOLOGY CO., LTD. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.